Archive for the ‘Treatment’ Category

PBS Propels Lyme Myths

http://  Approx. 5 Min

What You Need to Know to Stay Safe From Ticks and Lyme Disease This Summer

PBS NewsHour

According to the Centers for Disease Control, as many as 476,000 people in the U.S. contract Lyme disease every year. Climate change and human encroachment into wilderness areas means ticks and the disease-causing bacteria they carry are becoming more common. Dr. Linden Hu, an immunology professor and co-director of the Lyme Disease Initiative at Tufts University, joins John Yang to discuss.

________________

**Comment**

Same old myths regurgitated due to either Hu’s ignorance (hard to believe), and/or conflicts of interest because he needs to obtain research grants from the government which continues to push a 40-year old false narrative.

  • Most never see the tick or have a rash.
  • Antibiotics are NOT effective for most as relapses have occurred in virtually every study done.
  • The percentages Hu states goes onto suffer with chronic Lyme are flat-out wrong and only include those diagnosed and treated early.  A far greater percentage are not included in this tally as they are diagnosed and treated late.  When combined together, a whopping 60% or more develop chronic symptoms.
  • Independent research has shown “climate change” is a nothing-burger regarding tick and disease proliferation.
  • While I agree that animals help propagate Lyme/MSIDS, let us never forget our own government experimented on ticks by infecting them with numerous pathogens and then dumped them out of airplanes.
  • Hu predictably pushes a Lyme “vaccine” in both humans and mice.  This is the big cash-cow for research institutions and the government which gives a huge financial return on investment.  Meanwhile, patients continue to suffer without answers or relief.
  • The only time our government is concerned about the increasing numbers of Lyme/MSIDS is when they are pushing a “vaccine.”  Nothing is ever done about the fact we still don’t have an accurate test.

For more:

Case Report: Lyme Neuroborreliosis Triggers Multiple Strokes

https://danielcameronmd.com/lyme-neuroborreliosis-triggers-multiple-strokes/

CASE REPORT: LYME NEUROBORRELIOSIS TRIGGERS MULTIPLE STROKES

Lyme disease can trigger neurological complications. But neurovascular manifestations are far less common. In this case report, the authors describe a 58-year-old man who suffered multiple strokes due to Lyme neuroborreliosis.

In their article, “A case report of unilateral cerebral vasculitis in adults: keep in mind Lyme neuroborreliosis,” Riescher and colleagues examine the case of a 58-year-old man “with recurrent strokes in the same vascular territory without CSF pleocytosis, reflecting an unusual first manifestation of [Lyme neuroborreliosis].”¹

The authors point out that cerebral vasculitis is reported in only 0.3–1% of all Lyme neuroborreliosis cases, and unilateral or focal vasculitis have only rarely been described, almost exclusively in children.

In this case report, the patient, who had no medical history or cardiovascular risk factors, was admitted to the hospital with sudden right brachiofacial weakness. According to the authors, “He recovered partially, but facial palsy persisted.”

He was referred to the stroke unit but a neurological and general examination was normal.

“Cervical and intracranial CT angiography did not show any abnormalities such as stenosis, occlusion, or dilatation,” the authors wrote.

The man was diagnosed with cryptogenic stroke and prescribed aspirin (160  mg), atorvastatin (80 mg), and perindopril at 2 mg daily.

Two months later, the man exhibited sudden aphasia.

“Burgdorferi-induced cerebral vasculitis is thought to be a very rare manifestation of [Lyme neuroborreliosis]. But it must nonetheless be considered in the differential diagnosis of unexplained recurrent and/or multiple strokes.”

“MRI revealed a new and recent ischemic lesion in the left MCA territory visible on DWI, and another older lesion in the anterior cerebral artery (ACA) territory,” the authors wrote.

The patient was prescribed an oral anticoagulant and a cardiac monitor was inserted.

Over the next several months, the patient developed new symptoms including paresthesia (tingling sensation) in the right hand and foot, headaches, extreme weakness and lack of energy, psychomotor retardation, and unsteadiness.

Thirteen months after his first symptom appeared, he developed paresis (muscle weakness) in his right leg.

“A brain MRI showed a new recent ischemic lesion in the left cingulate cortex on DWI in the left ACA territory as well as other new lesions in the left MCA territory (in the frontal lobe),” the authors wrote.

Additional neurological testing was normal. However, Lyme disease testing was “highly positive” on ELISA and confirmed by Western blot.

The man was successfully treated with a one-month course of doxycycline.

“The patient experienced no further stroke after four weeks of doxycycline treatment.”

“In the following weeks, the patient reported dramatic improvement, with disappearance of his asthenia, dizziness, and right arm paresthesia,” the authors wrote.

The patient later reported that he had a tick bite 2 years prior to his first stroke, along with an erythema migrans rash but he never developed arthritis or pain.

Authors Conclude:

  • “Our patient stood out because he had recurrent ischemic strokes for more than one year (at least four episodes), without other associated symptoms, involving the ICA territory only, and without CSF pleocytosis, which is thought to be highly suggestive of LNB.”
  • “Burgdorferi-induced cerebral vasculitis is thought to be a very rare manifestation of [Lyme neuroborreliosis]. But it must nonetheless be considered in the differential diagnosis of unexplained recurrent and/or multiple strokes.”
  • “This case report reminds clinicians that it can occur without a history of a clear tick bite or erythema migrans, and cranial or peripheral neuritis and that the CSF examination can be normal.”
References:
  1. Riescher, S., Dos Santos, A., Lecomte, R. et al. A case report of unilateral cerebral vasculitis in adults: keep in mind Lyme neuroborreliosis. BMC Infect Dis 23, 283 (2023). https://doi.org/10.1186/s12879-023-08259-z

__________________

**Comment**

I’ve stated this before but it’s worth repeating: many Lyme/MSIDS patients improve by taking blood thinners or anti-coagulants like heparin, systemic enzymes, and things like serrapeptase, nattokinase & lumbrokinase which have a blood thinning effect.  Considering that many pathogens form biofilm, thinning and thereby cleaning the blood seems a logical step in helping treatment be more effective.

mRNA Will be Everywhere

http://

June 2, 2023

The Medical Establishment and Governments everywhere, are banking on this technology to be the future, along with 5G.  One must ask the question: why?

For more:

Vaccinating Mice to Protect People?

https://www.lymedisease.org/lyme-shield-vaccine-mice/

Vaccinating mice to protect people from Lyme disease

The US Department of Agriculture has conditionally licensed an oral Lyme vaccine that targets mice.

The substance is sprayed onto pellets and distributed in natural settings to be consumed by mice in the wild.

That vaccinates the mice against Lyme bacteria, so they will not pass the infection to ticks, which in turn cannot pass it to people and pets.

According to US Biologic, the maker of the vaccine, “We’ll distribute the pellets in different ways to residences, public lands, and commercial properties. At residences, we will use the LymeShield System, which is an integrated tick-management program offered by pest-management professionals and includes the timed-application LymeShield Station. “

The vaccine is called Borrelia Burgdorferi Bacterin. The product, called LymeShield, includes a device or “station” that holds and applies the pellets.

SOURCE: US Biologic

____________________

**Comment**

Sorry, just not excited about this at all.

There’s this thing called the law of unintended consequences and the past three years have demonstrated it perfectly.  Researchers and public health ‘authorities’ are typically very myopic and do not factor in variables that happen in real life that can affect the outcome of studies done in a lab in a petri dish.  The human body and the environment are complicated worlds where many things affect them.

For instance, what will these sprayed pellets do to other species that eat them?  What will this do to species that eat mice that have eaten these sprayed pellets?  What will this do to the groundwater that surrounds the area of these pellets and how will this affect wild-life and humans?  I mean, the questions abound here and no answers are forthcoming because we are all living in a continual experiment where we simply find out through the course of events.  Kind of like passing a bill before you read it.  (That actually happened)

For more:

Research has become a run-away train with zero oversight and zero ethics.  The world will suffer.

Please note that Lyme/MSIDS research always focuses on “vaccines” and never upon effective tests or treatments.  Coincidence?  I think not.

Could ‘New’ Antibiotic Prevent Chronic Lyme Disease?

https://news.northeastern.edu/2023/05/26/lyme-disease-treatment/

Could ‘new’ antibiotic treatment prevent chronic Lyme disease?

A tick is held by a pair of tweezers

Every year, tens of thousands of new Lyme disease patients find that their symptoms persist even after the standard course of antibiotic treatment.

Instead of being cured, they find their lives upturned by chronic Lyme, also called persistent or post-treatment Lyme. Symptoms include bone-deep fatigue, cognitive difficulties, arthritis, muscle and joint pain and intermittent fevers, chills and sweats that can go on for months or years.

While medical solutions have proved elusive, a researcher at Northeastern University says he has developed a treatment for Lyme disease that could prevent chronic Lyme from developing in the first place.

Kim Lewis, distinguished professor of biology and director of Northeastern’s Antimicrobial Discovery Center, says human trials of his discovery may begin as early as next year.

Final toxicity trials will continue this summer, but so far the treatment—an antibiotic known as hygromycin A—has not been toxic in animals and has effectively cleared Lyme disease in mice, Lewis says.

He says the real promise of hygromycin A in preventing chronic Lyme is that it is a targeted antibiotic that selectively kills Lyme disease-causing bacteria without damaging the beneficial bacteria in the patient’s microbiome.

According to Lewis’ theory, the broad spectrum antibiotics traditionally prescribed for Lyme disease, doxycycline and amoxicillin, cause havoc in the gut by wiping out the healthy balance of bacteria.

“The microbiome has now been linked to almost every aspect of our health, especially the development of the immune system,” Lewis says.

(See link for article)

________________

A few points:

  • While Lewis regurgitates that only 10% go on to develop chronic Lyme, the Bay Area Lyme Foundation, states that it’s closer to 34%.  Microbiologist Holly Ahern shows it may be 60% or more.  This matters because the greater the number, the more research money will be designated for it.
  • Hygomycin A is found in the soil and it is weak against most bacteria but very potent against spirochetes.
  • The final stage of animal toxicity studies will take place this summer and human trials may start next year.

For more: